In a world filled with COVID-19…

Cin can Strike At any Moment

It’s well known that neutrophils are a patient’s first line of defense against infection.1

Today, patients may pay a heavy price

CIN increases a patient’s risk of infection and disrupts their immune defense mechanisms, which may interfere with treatment.2

These repeated infections and subsequent lowered absolute neutrophil counts potentially result in chemotherapy treatment delays and dose reductions.2

They also could lead  to costly extended or repeated hospitalizations and eventually decreased survival.3,4v

When relative dose intensity (RDI) is affected, the consequences can be dire

Disrupted chemotherapy can directly compromise outcomes